Fly News Breaks for March 3, 2020
Mar 3, 2020 | 08:58 EDT
Canaccord analyst Richard Close noted Livongo Health posted solid Q4 results and provided guidance that exceeded consensus forecasts. He said the company's new services are gaining traction and its new business pipeline appears to be extremely strong and broad with large opportunities with health plans and federal and state government organizations. Close reiterated his Buy rating and $46 price target on Livongo Health shares.
News For LVGO From the Last 2 Days
There are no results for your query LVGO